NextCure (NXTC) Stock Price, Quote, News & History | Benzinga

SPY769.86+0.03%QQQ749.55−0.00%BTC/USD86,500.44−0.02%DIA511.70+0.12%GLD380.52+0.10%TLT77.53+0.06%

NextCure Inc (NXTC) Stock Price, Quote, News & History

NXTCNASDAQ

Trade with Public

Trade with Public

$5.09

0.132.62%

Last update: Oct 2, 5:56 PM

$5.42

0.469.27%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Stock Report

Key Statistics

Open

$5.17

Close

$5.09

Volume / Avg.

63.33K / 2.08M

Day Range

$4.85 - $5.40

52 Wk Range

1.55 - 15.74

Market Cap

$24.81M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

46

Short Interest

2.3%

Days to Cover

1.06

Recent NextCure Inc News

Why Aehr Test Systems Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket

Shares of Aehr Test Systems (NASDAQ: AEHR) jumped 29.6% to $93.30 in pre-market trading. Aehr Test Systems beats Q4 estimates and issues FY27 guidance above estimates.

Avi Kapoor

Nextcure Transforms Into Avere as Investors Back Oral Psoriasis Therapy

NextCure will merge with Avere in a $320 million exchange to advance oral IL-23 therapy AVR-001 and list the combined company as AVRX.

Vandana Singh

Dow Falls Over 100 Points Following Inflation Data; Crude Oil Gains

Stocks mixed, Dow falls over 100 points. Nasdaq up 0.88%, S&P up 0.32%. Tech shares surge 1.2%, healthcare falls 1.9%. Headline CPI drops, core CPI flat.

Avi Kapoor

Nasdaq Surges Over 100 Points; Bank of America Earnings Top Views

US stocks rise, Nasdaq gains 100 points. Dow up 0.18%, Nasdaq up 0.49%, S&P 500 up 0.26%. Materials sector up 1.5%, healthcare down 1.4%. Bank of America beats earnings expectations.

Avi Kapoor

What's Going On With NextCure Stock Wednesday?

NextCure ($NXTC) rises 2.1% premarket after presenting positive Phase 1 clinical data for ovarian cancer treatment SIM0505 at ASCO.

Kaustubh Bagalkote

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-36.98M

Investing Cash Flow (TTM)

25.79M

Financing Cash Flow (TTM)

21.56M

Free Cash Flow (TTM)

-36.98M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

10.37M

Analyst Trends and Forecast

1

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$6.81M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

1.90

Earnings Yield % (TTM)

-164.29%

Earnings Yield % (FWD)

-27.38%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$2.65

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$15.26M

Debt to Equity

0.30

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-